<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56-jof-07-00014">
 <label>56.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vigor</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Emerson</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Scott</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Cheek</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Barton</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bax</surname>
    <given-names>H.J.</given-names>
   </name>
   <name>
    <surname>Josephs</surname>
    <given-names>D.H.</given-names>
   </name>
   <name>
    <surname>Karagiannis</surname>
    <given-names>S.N.</given-names>
   </name>
   <name>
    <surname>Spicer</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Lentfer</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Development of downstream processing to minimize beta-glucan impurities in GMP-manufactured therapeutic antibodies</article-title>
  <source>Biotechnol. Prog.</source>
  <year>2016</year>
  <volume>32</volume>
  <fpage>1494</fpage>
  <lpage>1502</lpage>
  <pub-id pub-id-type="doi">10.1002/btpr.2359</pub-id>
  <?supplied-pmid 27604040?>
  <pub-id pub-id-type="pmid">27604040</pub-id>
 </element-citation>
</ref>
